BackPanbela Therapeutics Overview

Panbela Therapeutics Cost of Revenue

Cost of Revenue analysis for PBLA.

Quarterly Cost of Revenue

$7.17M
↓ 8.68% YoY

As of Sep 30, 2024

Annual Cost of Revenue (TTM)

$29.04M
↑ 43.62% YoY

Trailing 12 months ending Sep 30, 2024

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin